Fuji Pharma Co.,Ltd. (4554.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

22.0x

EV/EBITDA

5.6x

Market Cap

JPY 42.92B

MomentumView details →

1D Return

−0.45%

YTD Return

−6.67%

RSI (14)

35.7

ValuationView details →

P/E (Fwd)

22.0x

EV/EBITDA

5.6x

Market Cap

JPY 42.92B

RSI (14)

35.7

MomentumView details →

1D Return

−0.45%

YTD Return

−6.67%

ProfitabilityView details →

Gross Margin

36.24%

Net Margin

4.23%

EBITDA Margin

15.47%

ROE (TTM)

4.72%

ROA (TTM)

2.48%

Asset Turnover

0.59x

GrowthView details →

Revenue YoY

+17.31%

EPS YoY

−24.09%

FCF YoY

—

Revenue CAGR 3Y

+13.41%

EPS CAGR 3Y

+3.46%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.43x

Current Ratio

1.68x

Quick Ratio

1.46x

Div Yield

2.65%

Div Rate

JPY 45.50

Div Growth 1Y

+7.06%

Financials snapshotView financials →

Revenue (TTM)

54.57B

Net Income (TTM)

2.33B

Op. CF (TTM)

—

Next earningsNov 5, 2026 →

Latest newsMore news →

Fuji Pharma announced on August 17 that it obtained manufacturing and marketing approval for four generic drug products of one ingredient, pomalidomide capsules, for relapsed or refractory multiple myeloma.18d ago

Fuji Pharma Co., Ltd. announced that it was certified as a DX Certified Business Operator by Japan's Ministry of Economy, Trade and Industry, effective August 1, 2026.24d ago

Similar companies

Cuorips Inc.4894.T Daito Pharmaceutical Co.,Ltd.4577.T SEIKAGAKU CORPORATION4548.T Heartseed Inc.219A.T TAUNS Laboratories,Inc.197A.T MIZUHO MEDY CO.,LTD.4595.T Find similar companies →

Latest newsMore news →

Fuji Pharma announced on August 17 that it obtained manufacturing and marketing approval for four generic drug products of one ingredient, pomalidomide capsules, for relapsed or refractory multiple myeloma.18d ago Fuji Pharma Co., Ltd. announced that it was certified as a DX Certified Business Operator by Japan's Ministry of Economy, Trade and Industry, effective August 1, 2026.24d ago